MITCHELL ROBERT KHO: Open Payments
NPI 1891836862 · GLEN MILLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 14 payments from 7 companies in 2025. Trend: 2023 $100 · 2024 $124 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $114 |
| Alkermes, Inc. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: UZEDY, INVEGA SUSTENNA, HETLIOZ, LYBALVI, ARISTADA, ABILIFY MAINTENA, VRAYLAR, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
